Case of pemphigoid with immunoglobulin G antibodies to BP180 C-terminal domain and laminin-γ1 (p200) developed after pneumococcal vaccination.
BP180
laminin-γ1 (p200)
pemphigoid disease
pneumococcal vaccination
trigger
Journal
The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
28
04
2020
revised:
08
06
2020
accepted:
28
08
2020
pubmed:
26
9
2020
medline:
15
5
2021
entrez:
25
9
2020
Statut:
ppublish
Résumé
Pemphigoid cases have been reported in association with vaccination, including pneumococcal vaccination in infants but not in adults. There are also sporadic reports of pemphigoid diseases involving reactions to multiple autoantigens. We herein report a 75-year-old Japanese patient with pemphigoid who had immunoglobulin G antibodies to both the BP180 C-terminal domain and laminin-γ1 (p200), which developed 1 day after pneumococcal vaccination.
Identifiants
pubmed: 32974956
doi: 10.1111/1346-8138.15626
doi:
Substances chimiques
Autoantibodies
0
Autoantigens
0
Immunoglobulin G
0
Laminin
0
Non-Fibrillar Collagens
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
101-105Informations de copyright
© 2020 Japanese Dermatological Association.
Références
Venning VA, Wojnarowska F. Induced bullous pemphigoid. Clin Exp Dermatol 1995; 132(5): 831-832.
Fournier B, Descamps V, Bouscarat F, Crickx B, Belaich S. Bullous pemphigoid induced by vaccination. Br J Dermatol 1996; 135(1): 153-154.
Walmsley N, Hampton P. Bullous pemphigoid triggered by swine flu vaccination: case report and review of vaccine triggered pemphigoid. J Dermatol Case Rep 2011; 4: 74-76.
Chacón GR, Sinha AA. Bullous pemphigoid after herpes zoster vaccine administration: association or coincidence? J Drugs Dermatol 2011; 10: 1328-1330.
Sezin T, Egozi E, Hillou W, Avitan-Hersh E, Bergman R. Anti-laminin-332 mucous membrane pemphigoid developing after a diphtheria tetanus vaccination. JAMA Dermatol 2013; 149: 858-862.
Jindal A, Nayak SUK, Shenoi SD, Rao R, Monappa V. Bullous pemphigoid triggered by rabies vaccine. Indian J Dermatol Venereol Leprol 2020; 86: 66-68.
Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997; 46(RR-8): 1-24.
Goronzy JJ, Li G, Yang Z, Weyand CM. The janus head of T cell aging: autoimmunity and immunodeficiency. Front Immunol 2013; 4: 131.
Goto-Ohguchi Y, Nishie W, Akiyama M et al. A severe and refractory case of anti-p200 pemphigoid resulting in multiple skin ulcers and scar formation. Dermatology 2009; 218: 265-271.
Haneda T, Imai Y, Koga H, Hashimoto T, Yamanishi K. Case of subepidermal bullous dermatosis with immunoglobulin G autoantibodies against various basement membrane zone proteins. J Dermatol 2013; 40: 283-285.
Ansai S, Hashizume S, Kawana S et al. Case of anti-laminin gamma-1 pemphigoid with antibody against C-terminal domain of BP180 in a patient with psoriasis vulgaris. J Dermatol 2014; 41: 1031-1033.
Ishida S, Takahashi K, Kanaoka M et al. Case of subepidermal autoimmune bullous disease with psoriasis vulgaris reacting to both BP180 C-terminal domain and laminin gamma-1. J Dermatol 2015; 42: 391-393.
Imanishi A, Tateishi C, Imanishi H et al. Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: successful disease control with cyclosporin. J Dermatol 2015; 42: 394-397.
Goto-Hamano H, Ito K, Sakamoto-Kimura K et al. Autoantibodies against multiple epitopes in Bp180 and laminin gamma-1 in subepidermal blistering skin disease associated with psoriatic erythroderma. Indian J Dermatol 2015; 60: 521.
Di Zenzo G, Thoma-Uszynski S, Calabresi V et al. Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study. J Invest Dermatol 2011; 131: 2271-2280.